LENCI, EDOARDO
 Distribuzione geografica
Continente #
NA - Nord America 497
EU - Europa 146
AS - Asia 66
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 1
Totale 734
Nazione #
US - Stati Uniti d'America 497
IT - Italia 60
SE - Svezia 32
CN - Cina 30
IE - Irlanda 30
SG - Singapore 30
CI - Costa d'Avorio 17
GB - Regno Unito 8
MA - Marocco 7
IN - India 5
DE - Germania 4
UA - Ucraina 3
AT - Austria 2
BE - Belgio 2
FI - Finlandia 2
FR - Francia 2
EU - Europa 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 734
Città #
Chandler 94
Des Moines 93
New York 40
Fairfield 33
Dublin 30
Ashburn 29
Boardman 22
Ancona 20
Abidjan 17
Wilmington 17
Singapore 15
Houston 13
Ann Arbor 11
Seattle 11
Turin 11
Woodbridge 11
Jacksonville 10
Lawrence 10
Princeton 10
San Mateo 8
Pune 5
Arnold 4
Cambridge 4
London 4
San Diego 4
Washington 4
Cantu 3
Wuxi 3
Brussels 2
Castelraimondo 2
Fabriano 2
Falconara Marittima 2
Falls Church 2
Guangzhou 2
Helsinki 2
Jiaxing 2
Los Angeles 2
Vienna 2
Wuhan 2
Beijing 1
Bolton 1
Centro 1
Chongqing 1
Jinan 1
Kilburn 1
Mantova 1
Milan 1
Osimo 1
Prescot 1
Shanghai 1
Shaoxing 1
Shenzhen 1
Tolentino 1
Zibo 1
Totale 573
Nome #
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 105
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 93
Electrolyte disorders in cancer patients: a systematic review 87
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 72
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 68
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC 64
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer 62
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis 58
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 57
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 51
null 31
BRCA mutations and gastrointestinal cancers: When to expect the unexpected? 8
Totale 756
Categoria #
all - tutte 4.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 0 4 6
2020/202199 0 6 4 20 18 0 0 6 8 7 17 13
2021/202287 1 8 1 4 1 9 8 2 16 11 7 19
2022/2023330 18 30 15 22 11 117 0 13 51 3 43 7
2023/2024147 23 3 7 5 16 59 1 5 0 2 1 25
2024/202583 46 19 5 6 7 0 0 0 0 0 0 0
Totale 756